|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2023―Jul―11 |
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic |
Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S Fung, Pierre-Olivier Gaudreau |
2 |
[GO] |
2023―Jan―11 |
Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients |
Mehrsa Jalalizadeh, Cristiane F Giacomelli, Patricia AF Leme, Keini Buosi, Luciana SB Dal Col, Franciele AV Dionato, et al. (+4) Cristiane L Maia, Reza Yadollahvandmiandoab, Adilson P Domingues-Junior, Leonardo O Reis |
3 |
[GO] |
2022―Jul―27 |
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma |
Mikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, Ekaterina Orlova, Aleksandr Ivanov, Olga Belyakova, et al. (+9) Tatyana Vyaznikova, Natalia Selezneva, Anton Perevozchikov, Alina Sokolova, Nataliya Zubkova, Irina Efimova, Inna Dolzhikova, Denis Logunov, Elena Sakanjan |
4 |
[GO] |
2022―Jul―20 |
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19 |
Ragul Manoharan, Rajshekhar A Kore, Jawahar L Mehta |
5 |
[GO] |
2022―Jul―19 |
Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report |
Amalia Anastasopoulou, Aikaterini Gkoufa, Panagiotis Diamantopoulos, Spyridon Kazanas, Irene Eliadi, Michael Samarkos, Helen Gogas |
6 |
[GO] |
2022―Jul―05 |
Effectiveness of COVID-19 vaccines against Omicron variant |
Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Claudio Bruno Silva de Oliveira, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira |
7 |
[GO] |
2022―Jul―05 |
Reply to the letter ‘Effectiveness of COVID-19 vaccines against Omicron variant’ |
Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu, Vasso Apostolopoulos |
8 |
[GO] |
2022―Jun―13 |
Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report |
Angioletta Lasagna, Marco Vincenzo Lenti, Irene Cassaniti, Paolo Sacchi |
9 |
[GO] |
2022―Mrz―21 |
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment |
Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, Anselmo A Abdo Cuza, Yamilka Hernández Sánchez, Aylin Granado Rodríguez, et al. (+15) Sarahy Sepúlveda Figueroa, Egda M Llanez Gregorich, Mery L Torres Lahera, Francisco Gómez Peire, Teresita Montero González, Yaneth Zamora González, Ana L Añé Kouri, Addys González Palomo, Mayelin Troche Concepción, Loipa Medel Pérez, Patricia Lorenzo Luaces-Alvarez, Daymys Estévez Iglesias, Danay Saavedra Hernández, Mayra Ramos Suzarte, Tania Crombet Ramos |
10 |
[GO] |
2022―Feb―21 |
A global picture: therapeutic perspectives for COVID-19 |
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu, Vasso Apostolopoulos |
11 |
[GO] |
2021―Nov―22 |
Nimotuzumab for COVID-19: case series |
Anselmo A Abdo Cuza, Jonathan Pi Ávila, Rafael Machado Martínez, José Jordán González, Guillermo Pérez Aspuro, Juan A Gutiérrez Martínez, et al. (+4) Mayra Ramos Suzarte, Danay Saavedra Hernández, Ana L Añé-Kouri, Tania Crombet Ramos |
12 |
[GO] |
2021―Nov―08 |
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
Alexandre E Malek, Paulette Pinargote Cornejo, Nour Daoud, Mohammad Alam |
13 |
[GO] |
2021―Sep―29 |
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research |
Angioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli |
14 |
[GO] |
2021―Aug―25 |
Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis |
Wenwei Qian, Ying Ye, Lugen Zuo, Ting Song, Qing Xu, Yinghong Wang, et al. (+2) Jun Qian, Yun Tian |
15 |
[GO] |
2021―Jun―11 |
Appropriate use of antimicrobial therapy for COVID-19 co-infection |
Chih-Cheng Lai, Wen-Liang Yu |
16 |
[GO] |
2021―Apr―28 |
Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) |
Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante |
17 |
[GO] |
2021―Feb―09 |
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma |
Shaukat Ali, Syed M Uddin, Ayesha Ali, Fatima Anjum, Rashid Ali, Elisha Shalim, et al. (+7) Mujtaba Khan, Iqra Ahmed, Sheikh M Muhaymin, Uzma Bukhari, Shobha Luxmi, Abdul S Khan, Saeed Quraishy |
18 |
[GO] |
2021―Jan―05 |
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases |
Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, et al. (+11) Naivy Sánchez, Jorge Berrio, Geidy Lorenzo, Meylan Cepeda, Mayra Ramos, Danay Saavedra, Ana Laura Añe-Kouri, Zaima Mazorra, Kalet Leon, Tania Crombet, Armando Caballero |
19 |
[GO] |
2020―Dez―14 |
Immunity to glycan α-Gal and possibilities for the control of COVID-19 |
José de la Fuente, Christian Gortázar, Alejandro Cabezas-Cruz |
20 |
[GO] |
2020―Sep―22 |
COVID-19 and the newly rediscovered multidisciplinarity |
Melissa Bersanelli |
21 |
[GO] |
2020―Sep―16 |
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy |
Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, et al. (+9) Roberta Camisa, Michele Tognetto, Alberto Clemente, Diana Giannarelli, Sara Elena Rebuzzi, Alessandro Leonetti, Paola Bordi, Marcello Tiseo, Sebastiano Buti |
22 |
[GO] |
2020―Sep―09 |
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy |
Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, et al. (+2) Artur Katz, Rodrigo Ramella Munhoz |
23 |
[GO] |
2020―Sep―09 |
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins |
José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, et al. (+4) Joaquim Segalés, Isabel Sola, Luis Enjuanes, Rodrigo Gajardo |
24 |
[GO] |
2020―Jul―17 |
Obesity, COVID-19 and immunotherapy: the complex relationship! |
Carmine Finelli |
25 |
[GO] |
2020―Jul―15 |
Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients |
Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz, Álvaro A Faccini-Martínez, Carlos Eduardo Pérez-Díaz |
26 |
[GO] |
2020―Jul―09 |
How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology |
Ting Yi Jessica Chang, Janet E Pope |
27 |
[GO] |
2020―Jun―29 |
Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19 |
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba Ariela Brandes |
28 |
[GO] |
2020―Jun―17 |
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019 |
Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru |
29 |
[GO] |
2020―Jun―03 |
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors |
Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba |
30 |
[GO] |
2020―Mai―13 |
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens |
José-María Díez, Carolina Romero, Rodrigo Gajardo |
31 |
[GO] |
2020―Apr―30 |
COVID-19: the use of immunotherapy in metastatic lung cancer |
Alexander P Davis, Michael Boyer, Jenny H Lee, Steven C Kao |
32 |
[GO] |
2020―Apr―15 |
Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? |
Joseph Kattan, Clarisse Kattan, Tarek Assi |
33 |
[GO] |
2020―Mrz―26 |
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
Melissa Bersanelli |